The Annals of Otology, Rhinology, and Laryngology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Restarting Antithrombotic Therapies After Endoscopic Sinus Surgery: A Systematic Review
CONCLUSION: A paucity of literature exists on the resumption of antithrombotic therapies after ESS. As a major determining factor in patient morbidity, guideline-based resumption of these therapies is needed.PMID:38557289 | DOI:10.1177/00034894241245840 (Source: The Annals of Otology, Rhinology, and Laryngology)
Source: The Annals of Otology, Rhinology, and Laryngology - April 1, 2024 Category: ENT & OMF Authors: Trinithas Boyi Rhys L Richmond Darpan Kayastha R Peter Manes Ryan Rimmer Source Type: research
Restarting Antithrombotic Therapies After Endoscopic Sinus Surgery: A Systematic Review
CONCLUSION: A paucity of literature exists on the resumption of antithrombotic therapies after ESS. As a major determining factor in patient morbidity, guideline-based resumption of these therapies is needed.PMID:38557289 | DOI:10.1177/00034894241245840 (Source: The Annals of Otology, Rhinology, and Laryngology)
Source: The Annals of Otology, Rhinology, and Laryngology - April 1, 2024 Category: ENT & OMF Authors: Trinithas Boyi Rhys L Richmond Darpan Kayastha R Peter Manes Ryan Rimmer Source Type: research
Restarting Antithrombotic Therapies After Endoscopic Sinus Surgery: A Systematic Review
CONCLUSION: A paucity of literature exists on the resumption of antithrombotic therapies after ESS. As a major determining factor in patient morbidity, guideline-based resumption of these therapies is needed.PMID:38557289 | DOI:10.1177/00034894241245840 (Source: The Annals of Otology, Rhinology, and Laryngology)
Source: The Annals of Otology, Rhinology, and Laryngology - April 1, 2024 Category: ENT & OMF Authors: Trinithas Boyi Rhys L Richmond Darpan Kayastha R Peter Manes Ryan Rimmer Source Type: research
Restarting Antithrombotic Therapies After Endoscopic Sinus Surgery: A Systematic Review
CONCLUSION: A paucity of literature exists on the resumption of antithrombotic therapies after ESS. As a major determining factor in patient morbidity, guideline-based resumption of these therapies is needed.PMID:38557289 | DOI:10.1177/00034894241245840 (Source: The Annals of Otology, Rhinology, and Laryngology)
Source: The Annals of Otology, Rhinology, and Laryngology - April 1, 2024 Category: ENT & OMF Authors: Trinithas Boyi Rhys L Richmond Darpan Kayastha R Peter Manes Ryan Rimmer Source Type: research
Restarting Antithrombotic Therapies After Endoscopic Sinus Surgery: A Systematic Review
CONCLUSION: A paucity of literature exists on the resumption of antithrombotic therapies after ESS. As a major determining factor in patient morbidity, guideline-based resumption of these therapies is needed.PMID:38557289 | DOI:10.1177/00034894241245840 (Source: The Annals of Otology, Rhinology, and Laryngology)
Source: The Annals of Otology, Rhinology, and Laryngology - April 1, 2024 Category: ENT & OMF Authors: Trinithas Boyi Rhys L Richmond Darpan Kayastha R Peter Manes Ryan Rimmer Source Type: research
Restarting Antithrombotic Therapies After Endoscopic Sinus Surgery: A Systematic Review
CONCLUSION: A paucity of literature exists on the resumption of antithrombotic therapies after ESS. As a major determining factor in patient morbidity, guideline-based resumption of these therapies is needed.PMID:38557289 | DOI:10.1177/00034894241245840 (Source: The Annals of Otology, Rhinology, and Laryngology)
Source: The Annals of Otology, Rhinology, and Laryngology - April 1, 2024 Category: ENT & OMF Authors: Trinithas Boyi Rhys L Richmond Darpan Kayastha R Peter Manes Ryan Rimmer Source Type: research
Restarting Antithrombotic Therapies After Endoscopic Sinus Surgery: A Systematic Review
CONCLUSION: A paucity of literature exists on the resumption of antithrombotic therapies after ESS. As a major determining factor in patient morbidity, guideline-based resumption of these therapies is needed.PMID:38557289 | DOI:10.1177/00034894241245840 (Source: The Annals of Otology, Rhinology, and Laryngology)
Source: The Annals of Otology, Rhinology, and Laryngology - April 1, 2024 Category: ENT & OMF Authors: Trinithas Boyi Rhys L Richmond Darpan Kayastha R Peter Manes Ryan Rimmer Source Type: research
Restarting Antithrombotic Therapies After Endoscopic Sinus Surgery: A Systematic Review
CONCLUSION: A paucity of literature exists on the resumption of antithrombotic therapies after ESS. As a major determining factor in patient morbidity, guideline-based resumption of these therapies is needed.PMID:38557289 | DOI:10.1177/00034894241245840 (Source: The Annals of Otology, Rhinology, and Laryngology)
Source: The Annals of Otology, Rhinology, and Laryngology - April 1, 2024 Category: ENT & OMF Authors: Trinithas Boyi Rhys L Richmond Darpan Kayastha R Peter Manes Ryan Rimmer Source Type: research
Restarting Antithrombotic Therapies After Endoscopic Sinus Surgery: A Systematic Review
CONCLUSION: A paucity of literature exists on the resumption of antithrombotic therapies after ESS. As a major determining factor in patient morbidity, guideline-based resumption of these therapies is needed.PMID:38557289 | DOI:10.1177/00034894241245840 (Source: The Annals of Otology, Rhinology, and Laryngology)
Source: The Annals of Otology, Rhinology, and Laryngology - April 1, 2024 Category: ENT & OMF Authors: Trinithas Boyi Rhys L Richmond Darpan Kayastha R Peter Manes Ryan Rimmer Source Type: research
Restarting Antithrombotic Therapies After Endoscopic Sinus Surgery: A Systematic Review
CONCLUSION: A paucity of literature exists on the resumption of antithrombotic therapies after ESS. As a major determining factor in patient morbidity, guideline-based resumption of these therapies is needed.PMID:38557289 | DOI:10.1177/00034894241245840 (Source: The Annals of Otology, Rhinology, and Laryngology)
Source: The Annals of Otology, Rhinology, and Laryngology - April 1, 2024 Category: ENT & OMF Authors: Trinithas Boyi Rhys L Richmond Darpan Kayastha R Peter Manes Ryan Rimmer Source Type: research
Restarting Antithrombotic Therapies After Endoscopic Sinus Surgery: A Systematic Review
CONCLUSION: A paucity of literature exists on the resumption of antithrombotic therapies after ESS. As a major determining factor in patient morbidity, guideline-based resumption of these therapies is needed.PMID:38557289 | DOI:10.1177/00034894241245840 (Source: The Annals of Otology, Rhinology, and Laryngology)
Source: The Annals of Otology, Rhinology, and Laryngology - April 1, 2024 Category: ENT & OMF Authors: Trinithas Boyi Rhys L Richmond Darpan Kayastha R Peter Manes Ryan Rimmer Source Type: research
Restarting Antithrombotic Therapies After Endoscopic Sinus Surgery: A Systematic Review
CONCLUSION: A paucity of literature exists on the resumption of antithrombotic therapies after ESS. As a major determining factor in patient morbidity, guideline-based resumption of these therapies is needed.PMID:38557289 | DOI:10.1177/00034894241245840 (Source: The Annals of Otology, Rhinology, and Laryngology)
Source: The Annals of Otology, Rhinology, and Laryngology - April 1, 2024 Category: ENT & OMF Authors: Trinithas Boyi Rhys L Richmond Darpan Kayastha R Peter Manes Ryan Rimmer Source Type: research
Restarting Antithrombotic Therapies After Endoscopic Sinus Surgery: A Systematic Review
CONCLUSION: A paucity of literature exists on the resumption of antithrombotic therapies after ESS. As a major determining factor in patient morbidity, guideline-based resumption of these therapies is needed.PMID:38557289 | DOI:10.1177/00034894241245840 (Source: The Annals of Otology, Rhinology, and Laryngology)
Source: The Annals of Otology, Rhinology, and Laryngology - April 1, 2024 Category: ENT & OMF Authors: Trinithas Boyi Rhys L Richmond Darpan Kayastha R Peter Manes Ryan Rimmer Source Type: research
Restarting Antithrombotic Therapies After Endoscopic Sinus Surgery: A Systematic Review
CONCLUSION: A paucity of literature exists on the resumption of antithrombotic therapies after ESS. As a major determining factor in patient morbidity, guideline-based resumption of these therapies is needed.PMID:38557289 | DOI:10.1177/00034894241245840 (Source: The Annals of Otology, Rhinology, and Laryngology)
Source: The Annals of Otology, Rhinology, and Laryngology - April 1, 2024 Category: ENT & OMF Authors: Trinithas Boyi Rhys L Richmond Darpan Kayastha R Peter Manes Ryan Rimmer Source Type: research
Changes in Otitis Media During COVID-19
CONCLUSIONS: OM prevalence decreased by 45.0%, and the number of ventilating-tube insertions decreased by 28.1% in Korea during COVID-19.PMID:38545884 | DOI:10.1177/00034894241241889 (Source: The Annals of Otology, Rhinology, and Laryngology)
Source: The Annals of Otology, Rhinology, and Laryngology - March 28, 2024 Category: ENT & OMF Authors: Yongmin Cho Jong-Geun Lee Gi Hwan Ryu Jae-Jun Song Gi Jung Im Sung-Won Chae Source Type: research